Pharmafile Logo
Pharmafocus logo
Advanced Search
xofigo_bayer

NICE says ‘no’ to Xofigo

March 24, 2014
Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo

NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …

News
jenny_cowderoy

Former Google head to lead comms for M3


March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cowderoy, doctors.net, google, m3

Healthcare information provider M3 has appointed the former head of healthcare at Google as its managing director of communications in …

Appointment
EU flag image

Data transparency debate: Europe decides its future

March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency

Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …

Feature
Velcade image

NICE approves Velcade

March 21, 2014
Sales and Marketing Janssen, NHS, NICE, Velcade, myeloma

NICE has recommended Janssen’s proteasome inhibitor Velcade as an induction treatment for some patients with newly-diagnosed multiple myeloma. The draft …

News
Supercomputer image

IBM supercomputer could hold key to brain cancer

March 21, 2014
Medical Communications, Sales and Marketing avastin, brain cancer, ibm, nygc, supercomputer

The New York Genome Center and IBM Watson have joined forces to accelerate a new era of genomic medicine, initially …

News
dave_piacquad

Amgen names senior VP of Business Development

March 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, David Piacquad

Amgen has confirmed the appointment of David Piacquad to the new position of senior vice president of its Business Development …

Appointment
EMA image

EMA launches speedy pilot

March 21, 2014
Sales and Marketing BIA, EMA, MHRA, NICE, early access, trials

The European Medicines Agency (EMA) has launched an initiative aimed at speeding up the drug approval process and wants help …

News
Cairns image

AstraZeneca banks on MasterCard for director

March 20, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Johansson, ann cairns, british gas, mastercard

AstraZeneca is proposing to elect the president of International Markets for MasterCard to stand as a non-executive director on its …

News
Vodaphone image

AstraZeneca signs Vodafone contract

March 20, 2014
Medical Communications, Sales and Marketing AstraZeneca, cardiovascular, mhealth, vodaphone

AstraZeneca has signed up with phone operator Vodafone to provide mobile health (mHealth) services for patients suffering from cardiovascular issues. …

News
GSK image

GSK cancer vaccine fails again

March 20, 2014
Sales and Marketing Cancer, GSK, MAGE-A3 cancer immunotherapeutic, NSCLC, lung cancer, melanoma

GlaxoSmithKline’s MAGE-A3 cancer immunotherapeutic has delivered another late-stage blow to the firm but it still vows to continue trials.  The …

News
george_osborne_budget_day_2014

BIA welcomes budget statement

March 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme

An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …

News
screen_shot_2014-03-20_at_07

Takeda hires head of emerging markets

March 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, giles platford

Giles Platford has been appointed head of commercial operations, emerging markets for Swiss-based pharma firm Takeda. Reporting to its chief …

Appointment
FDA image

FDA ‘not trusted’ by Americans

March 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, JAMA, MMR, US, america, conspiracy, yougov

More than one-third of Americans in a new survey think the Food and Drug Administration is holding back new cures …

News
Allergan image

Allergan reprimanded over Botox promotion

March 19, 2014
Medical Communications, Sales and Marketing ABPI, Allergan, Botox, Galderma, PMCPA, vistabel

Allergan has been found guilty of breaching six clauses of the ABPI’s Code of Practice over its market research for …

News
meeta_gulyani_merck_serono

Merck Serono appoints head of strategy from Roche

March 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Meeta Gulyani, Merck Serono, Roche

Merck Serono the German biopharma division of Merck has appointed Meeta Gulyani to the position of head of strategy and …

Appointment

Europe: TB treatment ‘far below’ target

March 19, 2014
Research and Development, Sales and Marketing EU, MDR TB, TB, WHO, tuberculosis

European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …

News
Amgen image

Success for Amgen’s ‘bad’ cholesterol injection

March 18, 2014
Research and Development, Sales and Marketing Amgen, LDL, PCSK9, evolocumab, hofh, tesla

An investigational PCSK9 Inhibitor from Amgen has reduced LDL-C (‘bad’ cholesterol) in patients suffering from a rare genetic disorder in …

News
BMS image

BMS hopes for Yervoy sequel with new deal

March 18, 2014
Research and Development, Sales and Marketing Avapro, BMS, Plavix, Yervoy, five prime, immune-oncology

Bristol-Myers Squibb has announced a new research and development deal with Five Prime Therapeutics aimed at discovering potentially new cancer …

News

Pfizer sues over Viagra generic

March 18, 2014
Sales and Marketing ED, FDA, Pfizer, Sildenafil, torrent, viagra

Pfizer is suing Torrent Pharmaceuticals in order to stop it selling copycat versions on its big-selling erectile-dysfunction drug Viagra. The …

News
Patheon image

Patheon completes $2.65 billion merger with DSM

March 18, 2014
Manufacturing and Production, Sales and Marketing CDMO, DSM, Patheon, dpx, manufacturing

The $2.65 billion merger between Patheon and DSM’s pharma business has completed, creating a new privately-held company called DPx.  The …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026